Rachel Klein

Rachel Klein, MS, CGC, is Director of Program Business Development at Boston Children’s Hospital and part of the GUARDIAN study team, which is advancing whole genome sequencing in newborn screening. She previously held leadership roles at GeneDx and BioReference Laboratories, overseeing clinical operations and expanding access to genomic services. A licensed, board-certified genetic counselor with an MS from Sarah Lawrence College, Rachel has led multidisciplinary teams, presented nationally, and published in peer-reviewed journals. She is a former president of the Human Genetics Association of New Jersey and is dedicated to the ethical and equitable use of genomics in public health.